How to buy Aphria shares

Own Aphria shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Tilray, Inc (APHA) is a leading drug manufacturers-specialty & generic business with stocks listed in Canada. It opened the day at CADC$C$N/A after a previous close of CADC$C$N/A. During the day the price has varied from a low of CADC$N/A to a high of CADC$N/A. Aphria is listed on the TO. All prices are listed in Canadian Dollars.

How to buy shares in Aphria

  1. Compare share trading platforms. To buy shares in a company that's listed outside of Australia, you'll need to find a trading platform that offers access to global stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Aphria. Find the share by name or ticker symbol: APHA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aphria reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Aphria, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Aphria. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Aphria share price

Use our graph to track the performance of APHA stocks over time.

Aphria shares at a glance

Information last updated 2021-06-16.
OpenC$N/A
HighC$N/A
LowC$N/A
CloseC$N/A
Previous closeC$N/A
Change C$N/A
Change % N/A%
Volume 0
Information last updated 2021-06-04.
52-week rangeC$5.43 - C$30.7
50-day moving average C$21.7961
200-day moving average C$19.2083
Target priceC$18.54
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) C$0.116
Promoted
eToro Share Trading (US stocks)

Invest in Aphria shares with $0 brokerage

Join the world's biggest social trading network now!

  • $0 brokerage for US stocks
  • Trades starting from $50
  • Fractional shares
  • Copy top traders

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro Share Trading (US stocks)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Aphria stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is Aphria under- or over-valued?

Valuing Aphria stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aphria's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Aphria's EBITDA

Aphria's EBITDA (earnings before interest, taxes, depreciation and amortisation) is CADC$9 million.

The EBITDA is a measure of a Aphria's overall financial performance and is widely used to measure a its profitability.

Aphria financials

Revenue TTM CADC$611.1 million
Gross profit TTM CADC$191 million
Return on assets TTM -1.31%
Return on equity TTM -34.14%
Profit margin -95.82%
Book value C$4.76
Market capitalisation CADC$4.4 billion

TTM: trailing 12 months

Shorting Aphria shares

There are currently 12.0 million Aphria shares held short by investors – that's known as Aphria's "short interest". This figure is 41.7% up from 8.4 million last month.

There are a few different ways that this level of interest in shorting Aphria shares can be evaluated.

Aphria's "short interest ratio" (SIR)

Aphria's "short interest ratio" (SIR) is the quantity of Aphria shares currently shorted divided by the average quantity of Aphria shares traded daily (recently around 3.4 million). Aphria's SIR currently stands at 3.52. In other words for every 100,000 Aphria shares traded daily on the market, roughly 3520 shares are currently held short.

However Aphria's short interest can also be evaluated against the total number of Aphria shares, or, against the total number of tradable Aphria shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aphria's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Aphria shares in existence, roughly 50 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Aphria shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aphria.

Find out more about how you can short Aphria stock.

Aphria share dividends

We're not expecting Aphria to pay a dividend over the next 12 months.

Have Aphria's shares ever split?

Aphria's shares were split on a 1:10 basis on 7 December 2014. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aphria shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aphria shares which in turn could have impacted Aphria's share price.

Aphria share price volatility

Over the last 12 months, Aphria's shares have ranged in value from as little as CADC$5.43 up to CADC$30.7. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (TO average) beta is 1, while Aphria's is 2.6198. This would suggest that Aphria's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aphria overview

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform